Skip to Main Content
Biological & Biomedical Sciences
Yale Home

INFORMATION FOR

    Diseases of the Cardiovascular System, Phase II-III

    DAL-302

    What is the purpose of this trial?

    The dal-GenE-2 clinical research study is testing an investigational medication to treat Acute Coronary Syndrome (ACS) in those who have the target gene variant. The DAL-302 study evaluates the effect of dalcetrapib (Study drug) on the risk of having a major cardiovascular event, including death, heart attack, and stroke.

    • Ages
      45 years and older
    • Gender
      Both
    Find out more about who can participate in this trial

    Contact Information

    For more information about this study, including how to volunteer, contact David Kingsbury, BSN RN

    Help Us Discover!

    You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

    Create a volunteer profile

    Principal Investigator

    Sub-Investigators

    • Last Updated
      11/26/2025
    • Study IRB
      #2000039690

    Contact Information

    For more information about this study, including how to volunteer, contact David Kingsbury, BSN RN